Filtered By:
Vaccination: Varicella-Zoster Virus Vaccine
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 252 results found since Jan 2013.
Herpetic anterior uveitis following Pfizer –BioNTech coronavirus disease 2019 vaccine: two case reports
ConclusionClinicians should be aware of the possibility of eye inflammation in the form of herpetic reactivation after coronavirus disease 2019 vaccination.
Source: Journal of Medical Case Reports - March 25, 2022 Category: General Medicine Source Type: research
Herpetic anterior uveitis following Pfizer-BioNTech coronavirus disease 2019 vaccine: two case reports
CONCLUSION: Clinicians should be aware of the possibility of eye inflammation in the form of herpetic reactivation after coronavirus disease 2019 vaccination.PMID:35337364 | DOI:10.1186/s13256-022-03350-6
Source: Herpes - March 26, 2022 Category: Infectious Diseases Authors: Jos é Manuel Ortiz-Egea Cristina G ómez Sánchez Andr és López-Jiménez Olga Diego Navarro Source Type: research
Herpes zoster following vaccination with ChAdOx1 nCoV-19 Coronavirus vaccine (recombinant)
We report a case series of 7 patients who developed herpes zoster (HZ) following the first dose of ChAdOx1 nCoV-19 coronavirus vaccine (recombinant). HZ following vaccination is a rare entity. The occurrence of HZ in the patients presented in this series within the time window 1–21 days after vaccination defined for increased risk and postulated dysregulation of T-cell-mediated immunity, suggests that the ChAdOx1 nCoV-19 coronavirus vaccine (recombinant) could probably be a trigger for reactivation of varicella zoster virus to cause HZ in them.
Source: Indian Journal of Public Health - April 5, 2022 Category: International Medicine & Public Health Authors: Anupa Mary Job Bindurani Sudhamani Manju Mohan SN Mohanasundaram Source Type: research
Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2 vaccination or infection: New insights
CONCLUSION: This study indicates that the occurrence of VZV reactivation is clinically relevant. However, our findings suggest that COVID-19 vaccination is safe, and remains strongly recommended.PMID:35931613 | DOI:10.1016/j.ejim.2022.07.022
Source: Herpes - August 5, 2022 Category: Infectious Diseases Authors: Raquel Martinez-Reviejo Sofia Tejada Ganiyat A R Adebanjo Camilla Chello Miriam C Machado Francesca R Parisella Magda Campins Antonella Tammaro Jordi Rello Source Type: research
Multiregional Population-Based Cohort Study for Evaluation of the Association Between Herpes Zoster and mRNA Vaccinations for Severe Acute Respiratory Syndrome Coronavirus-2: The VENUS Study
CONCLUSIONS: No increased risk of HZ was found after BNT162b2 vaccination in the overall study population. However, an increased risk was observed in the younger subgroup.PMID:37404955 | PMC:PMC10316690 | DOI:10.1093/ofid/ofad274
Source: Herpes - July 5, 2023 Category: Infectious Diseases Authors: Chieko Ishiguro Wataru Mimura Yukari Uemura Megumi Maeda Fumiko Murata Haruhisa Fukuda Source Type: research
Management of coronavirus disease 2019 vaccine-induced cutaneous complications: A comprehensive literature review
J Family Community Med. 2023 Jul-Sep;30(3):161-170. doi: 10.4103/jfcm.jfcm_3_23. Epub 2023 Jul 24.ABSTRACTDespite the numerous reports of cutaneous manifestations associated with vaccines for coronavirus disease 2019 (COVID-19), the relationship between COVID-19 vaccines and cutaneous side effects remains unevaluated. In this review, we examine these manifestations and their management. Reported dermatoses included injection-site reaction (early and delayed), type I allergic reaction, morbilliform eruption, pityriasis rosea, Sweet syndrome, lichen planus, psoriasis, herpes zoster reactivation, erythema multiforme, Stevens-...
Source: Herpes - September 7, 2023 Category: Infectious Diseases Authors: Nouf F Bin Rubaian Abdullah A Aljalfan Serene R Almuhaidib Source Type: research
Trigeminal neuropathy after tozinameran vaccination against COVID-19 in postmicrovascular decompression for trigeminal neuralgia: illustrative case
J Neurosurg Case Lessons. 2022 Apr 18;3(16):CASE22101. doi: 10.3171/CASE22101. Print 2022 Apr 18.ABSTRACTBACKGROUND: Vaccines against coronavirus disease 2019 have a high level of efficacy and safety across all populations. However, numerous case series have been published on neurological disorders, including Bell's palsy, Guillain-Barre syndrome, transverse myelitis, and multiple sclerosis. The authors presented a case of trigeminal neuropathy after coronavirus vaccination in a patient who had undergone microvascular decompression (MVD) for trigeminal neuralgia (TN).OBSERVATIONS: A 77-year-old woman presented with acute t...
Source: Herpes - October 28, 2022 Category: Infectious Diseases Authors: Keisuke Onoda Ryohei Sashida Ren Fujiwara Tomihiro Wakamiya Yuhei Michiwaki Tatsuya Tanaka Kazuaki Shimoji Eiichi Suehiro Fumitaka Yamane Masatou Kawashima Akira Matsuno Source Type: research
